We are live on
!
Find out more
YIH
Y-Intercept (HK) Portfolio holdings
AUM
$5.05B
1-Year Est. Return
17.89%
This Fund
S&P 500
This Quarter
Est. Return
-6.93%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
–
AUM
$1,000M
AUM Growth
+$239M
(+31%)
Cap. Flow
+$349M
Cap. Flow
% of AUM
34.94%
Top 10 Holdings %
Top 10 Hldgs %
8.93%
Holding
1,387
New
562
Increased
225
Reduced
140
Closed
460
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$12M |
| 2 |
Verizon
VZ
|
+$11.7M |
| 3 |
Comcast
CMCSA
|
+$10.3M |
| 4 |
Procter & Gamble
PG
|
+$7.96M |
| 5 |
LBRDK
Liberty Broadband Class C
LBRDK
|
+$6.85M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marathon Petroleum
MPC
|
+$8.93M |
| 2 |
Amgen
AMGN
|
+$5.81M |
| 3 |
ConocoPhillips
COP
|
+$5.66M |
| 4 |
Illumina
ILMN
|
+$5.4M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$5.32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.53% |
| 2 | Financials | 12% |
| 3 | Consumer Discretionary | 11.85% |
| 4 | Industrials | 10.6% |
| 5 | Healthcare | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Neurocrine Biosciences
NBIX
$15.3B
| $387K | 0.04% |
+3,645
| New | +$370K |
|
627
iShares Russell 3000 ETF
IWV
$20.2B
| $387K | 0.04% |
+1,869
| New | +$430K |
|
628
BioMarin Pharmaceuticals
BMRN
$12.6B
| $386K | 0.04% |
+4,556
| New | +$406K |
|
629
Blue Owl Capital
OBDC
$5.64B
| $385K | 0.04% |
37,158
+13,739
| +59% | +$175K |
|
630
Host Hotels & Resorts
HST
$15.1B
| $385K | 0.04% |
24,249
-55,064
| -69% | -$960K |
|
|
WRK
631
DELISTED
WestRock Company
WRK
| $385K | 0.04% |
12,452
-776
| -6% | -$30.7K |
|
632
Global Net Lease
GNL
$2.05B
| $382K | 0.04% |
+35,896
| New | +$500K |
|
633
Lattice Semiconductor
LSCC
$15.5B
| $378K | 0.04% |
7,674
-13,526
| -64% | -$749K |
|
|
MCHB
634
Mechanics Bancorp
MCHB
$3.42B
| $375K | 0.04% |
+13,013
| New | +$458K |
|
635
Enviri
NVRI
$591M
| $374K | 0.04% |
99,947
+76,731
| +331% | +$425K |
|
636
Novanta
NOVT
$5.08B
| $369K | 0.04% |
+3,189
| New | +$435K |
|
637
BioCryst Pharmaceuticals
BCRX
$2.21B
| $368K | 0.04% |
+29,226
| New | +$376K |
|
638
Sony
SONY
$139B
| $368K | 0.04% |
28,705
-43,155
| -60% | -$691K |
|
639
Clean Energy Fuels
CLNE
$379M
| $365K | 0.04% |
+68,374
| New | +$428K |
|
|
ISEE
640
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $364K | 0.04% |
+20,309
| New | +$267K |
|
|
LEG
641
DELISTED
Leggett & Platt
LEG
| $363K | 0.04% |
+10,931
| New | +$415K |
|
642
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.8B
| $363K | 0.04% |
+2,981
| New | +$404K |
|
643
Merck
MRK
$363B
| $362K | 0.04% |
+4,209
| New | +$376K |
|
644
State Street SPDR S&P Biotech ETF
XBI
$10.6B
| $357K | 0.04% |
+4,505
| New | +$380K |
|
645
CorVel
CRVL
$3.58B
| $357K | 0.04% |
+7,731
| New | +$401K |
|
646
Trump Media & Technology Group
DJT
$2.41B
| $356K | 0.04% |
21,200
+5,994
| +39% | +$158K |
|
647
Sonoco
SON
$4.84B
| $356K | 0.04% |
+6,280
| New | +$386K |
|
648
GrafTech
EAF
$209M
| $356K | 0.04% |
8,251
-502
| -6% | -$31.9K |
|
|
NVEI
649
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $355K | 0.04% |
+13,140
| New | +$429K |
|
|
VISN
650
Vistance Networks Inc
VISN
$1.5B
| $355K | 0.04% |
+38,546
| New | +$369K |
|
Similar funds
BGDI
WAM
TSC
MS
GIBU
YCM
ONB
VDI
Y-Intercept (HK)'s Q3 2022 Portfolio in Review
As of Q3 2022, Y-Intercept (HK) held 1,387 positions worth $1,000M, up 31% from $761M the previous quarter. Its ten largest holdings account for 8.9% of the portfolio.
Y-Intercept (HK) deployed $349M of net new capital in Q3 2022, opening 562 new positions and adding to 225 existing holdings. Its largest new stake was Chevron: 78,786 shares worth $11.3M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Marathon Petroleum, an estimated $8.93M trimmed.
- Y-Intercept (HK)'s largest Q3 2022 buy was Chevron: 78,786 shares worth $11.3M.
- Y-Intercept (HK) added most to Comcast in Q3 2022, an estimated $10.3M increase.
- Y-Intercept (HK)'s biggest Q3 2022 reduction was Marathon Petroleum, cutting an estimated $8.93M.
- Y-Intercept (HK) fully exited Amgen in Q3 2022, selling an estimated $5.81M.
- Y-Intercept (HK)'s ten largest holdings make up 8.9% of its $1,000M portfolio in Q3 2022.
- Y-Intercept (HK) opened 562 new positions and closed 460 in Q3 2022.
- Y-Intercept (HK)'s portfolio value rose 31% quarter-over-quarter to $1,000M.
Based on Y-Intercept (HK)'s 13F filing for Q3 2022, filed 14 Feb 2023.